COOPER COMPANIES, INC. (COO)
Ophthalmic Goods · Healthcare · $12.8B
Intrinsic Value (Consensus)
$31.48
Current Price
$65.93
Margin of Safety
-52.3%
52.3% Above Intrinsic Value
Value: $31
Price: $66
Valuation Model Estimates
Current Price: $65.93
DCF (Discounted Cash Flow)
$28.21
Graham Number
$42.17
Earnings Power Value
$18.16
Relative Value (P/E)
$37.40
Dividend Discount Model
$0.72
Consensus Value
$31.48
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
53
Profitability
12/25
Strength
24/25
Valuation
7/25
Growth
10/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $1.87
- EPS (Forward)
- $1.91
- Book Value
- $42.27
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 4.6%
- Debt/Equity
- 30%
- Revenue Growth
- 5.1%
- Earnings Growth
- 2.0%
- Dividend Yield
- 0.2%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance